![Laurent Fischer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Laurent Fischer
Algemeen Directeur bij ADVERUM BIOTECHNOLOGIES, INC.
Vermogen: 701 475 $ op 30-06-2024
Oorsprong van het eerstegraads netwerk van Laurent Fischer
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
72
| Subsidiary | Pharmaceuticals: Major | 72 |
Frazier Management LLC
![]() Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.
60
| Subsidiary | Investment Managers | 60 |
Public Company | Pharmaceuticals: Major | 38 | |
Public Company | Pharmaceuticals: Major | 36 | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.
28
| Subsidiary | Biotechnology | 28 |
Public Company | Pharmaceuticals: Major | 27 | |
dpa Deutsche Presse-Agentur GmbH
![]() dpa Deutsche Presse-Agentur GmbH Internet Software/ServicesTechnology Services dpa Deutsche Presse-Agentur GmbH publishes on-line news. It develops and produces multimedia news products for the Web, mobile portal, and print applications, as well as engages in managing mobile services for media companies, providing cross media services for newspapers, international still graphics, and offers picture agency services. The company was founded in 1949 and is headquartered in Hamburg, Germany.
21
| Private Company | Internet Software/Services | 21 |
Subsidiary | Pharmaceuticals: Major | 16 | |
Tobira Therapeutics, Inc. /Old/
![]() Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.
16
| Extinct | Pharmaceuticals: Major | 16 |
Ocera Therapeutics, Inc. /Old/
![]() Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases.
10
| Extinct | Pharmaceuticals: Major | 10 |
DuPont Pharmaceuticals Co.
![]() DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
FORM Life Ventures
![]() FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg.
8
| Private Company | Investment Managers | 8 |
DuPont Merck Pharmaceutical Co.
![]() DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
SillaJen Biotherapeutics, Inc.
![]() SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Auxeris Therapeutics, Inc.
![]() Auxeris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Auxeris Therapeutics, Inc. manufactures drugs for osteoporosis, bone metastasis and other bone diseases. The company was founded in 2002 and is located in St. Louis, MO
3
| Extinct | Pharmaceuticals: Major | 3 |
Lycia Therapeutics, Inc.
![]() Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA.
3
| Holding Company | Biotechnology | 3 |
Rxcentric, Inc.
2
| Extinct | Packaged Software | 2 |
Vytal, Inc.
![]() Vytal, Inc. Drugstore ChainsRetail Trade Vytal, Inc. provides medication access, adherence, and direct-to-patient consumer programs. It offers prescription assistance, patient engagement, anticipatory logistic solutions, and omni-channel platform. The company was founded Levin Scott Bechtler, Paul Cattaneo, and Robert J. Feeney Jr. in 2000 and is headquartered in San Diego, CA.
2
| Holding Company | Drugstore Chains | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Laurent Fischer via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Graduate Degree Undergraduate Degree Undergraduate Degree | |
GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
ATAI Life Sciences AG
![]() ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Founder Founder Chief Operating Officer Chief Executive Officer | |
ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Founder Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Santa Clara University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Harvard Medical School | College/University | Graduate Degree Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of California, Irvine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
RENOVARO INC. | Biotechnology | Director/Board Member Director/Board Member | |
ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IMAGO BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard Law School | College/University | Graduate Degree Graduate Degree | |
MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member | |
SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Cerexa, Inc.
![]() Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Nodality, Inc.
![]() Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
University of London | College/University | Undergraduate Degree Doctorate Degree | |
ABBVIE INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
REPROS THERAPEUTICS INC | Pharmaceuticals: Major | President Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 45 |
Verenigd Koninkrijk | 4 |
Duitsland | 2 |
Canada | 2 |
Zwitserland | 2 |
Sectoraal
Health Technology | 36 |
Consumer Services | 15 |
Finance | 2 |
Operationeel
Director/Board Member | 549 |
Corporate Officer/Principal | 241 |
Independent Dir/Board Member | 184 |
Chief Executive Officer | 109 |
Chairman | 88 |
Sterkste connecties
Insiders | |
---|---|
Eckard Weber | 46 |
Christian Angermayer | 45 |
Patrick Heron | 42 |
Timothy Walbert | 40 |
Thomas Woiwode | 39 |
Brenton Saunders | 38 |
Ambrose Bailey | 32 |
Michael Grey | 32 |
Reed Tuckson | 31 |
Michael Auerbach | 31 |
Clarence Machado | 31 |
Albert Cha | 30 |
Laura Brege | 27 |
James Sapirstein | 26 |
Jim Scopa | 26 |
- Beurs
- Insiders
- Laurent Fischer
- Bedrijfsconnecties